Children with SJIA complicated by MAS respond better to anakinra treatment rather than anti-TNF therapy indicating the critical importance of IL-1 family cytokines in driving MAS [39]. The gene discussed is IL1B; the disease is systemic-onset juvenile idiopathic arthritis.